Dexmedetomidine in Children: Current Knowledge and Future Applications

  title={Dexmedetomidine in Children: Current Knowledge and Future Applications},
  author={Keira P. Mason and Jerrold Lerman},
  journal={Anesthesia \& Analgesia},
More than 200 studies and reports have been published regarding the use of dexmedetomidine in infants and children. We reviewed the English literature to summarize the current state of knowledge of this drug in children for the practicing anesthesiologist. Dexmedetomidine is an effective sedative for infants and children that only minimally depresses the respiratory system while maintaining a patent airway. However, dexmedetomidine does depress the cardiovascular system. Specifically… 

Figures from this paper

Combined Dexmedetomidine and Ketamine in Pediatric Anesthesia: A Brief Review

The literature is favorable to the use of KD for invasive and noninvasive procedures, inside and outside of the operating room, presenting an attractive profile for pediatric patients.

Dexmedetomidine as a Rapid Bolus for Treatment and Prophylactic Prevention of Emergence Agitation in Anesthetized Children

DEX reduced the incidence of postoperative opioid administration, and a trend of fewer adverse events was observed in group DEX, the largest group of children undergoing tonsillectomy with or without adenoidectomy.

Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations.

This review focuses on the current paediatric perioperative and periprocedural applications of dexmedetomidine and its limitations, with a consideration for the future.

Dexmedetomidine decreases stress post-operative in pediatrics

ABSTRACT Introduction Tracheal extubation causes hypertension and tachycardia. These associated hemodynamic changes are due to sympathetic discharge due to epipharyngeal and laryngeal stimulation.(1)

Comparison of dexmedetomidine with chloral hydrate as sedatives for pediatric patients

Abstract Background: Dexmedetomidine (Dex) and chloral hydrate (CH) are the most frequently used sedative agents in pediatric patients. We aimed to systematically review the literature comparing the

Intravenous dexmedetomidine augments the oculocardiac reflex.

  • R. SinhaK. Kumar
  • Medicine, Biology
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
  • 2019

To Pretreat or Not to Pretreat: Prophylactic Anticholinergic Administration Before Dexmedetomidine in Pediatric Imaging

Administration of a prophylactic anticholinergic with Dex shows no advantage other than a transient clinically insignificant increase in HR and SBP, and it may precipitate transient exaggerated SBP in more patients compared with not using a pro phytochemicals.

Dexmedetomidine for Sedation During Noninvasive Ventilation in Pediatric Patients*

Dexmedetomidine was often effective as a single continuous sedative infusion during pediatric noninvasive ventilatory during PICU admission over a 6-month period, and cardiorespiratory events associated with its use were typically mild and/or reversible.

Effect of Dexmedetomidine on Sevoflurane Requirements and Emergence Agitation in Children Undergoing Ambulatory Surgery

Intraoperative infusion of dexmedetomidine reduced sevoflurane requirements and decreased emergence agitation without delaying discharge in children undergoing ambulatory surgery, however, caution should be taken in regard to bradycardia and hypotension.

Population Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Children Undergoing Ambulatory Surgery

The results suggest that in Mexican children 2–18 years of age with American Society of Anesthesiologists physical status score of I/II, the DEX dose should be adjusted in accordance with lower DEX clearance.



The use of dexmedetomidine in critically ill children

  • Angela S CzajaJ. Zimmerman
  • Medicine
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
  • 2009
It is suggested that many, although not all, mechanically ventilated children may be able to reduce their need for other sedation medications with the use of dexmedetomidine, however, the potential side effects of Dexmedetamidine necessitates close hemodynamic monitoring with its use.

Prolonged dexmedetomidine infusions in critically ill infants and children.

Prolonged DEX infusions were associated with a reduction in concomitant analgesia and sedation medications and was well tolerated with the exception of heart rate, which decreased during the initiation of therapy but may not represent a clinically significant reduction.

Dexmedetomidine: Clinical update

Summary Dex is a sedative agent that acts via a unique alpha-2 agonist mechanism. It produces sedation while frequently preserving the ability of the patient to interact with other individuals such

The Effects of Dexmedetomidine on Cardiac Electrophysiology in Children

The use of DEX may not be desirable during electrophysiology study and may be associated with adverse effects in patients at risk for bradycardia or atrioventricular nodal block.

Use of dexmedetomidine in children after cardiac and thoracic surgery*

  • C. ChrysostomouS. Di Filippo R. Munoz
  • Medicine
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
  • 2006
The data suggest that dexmedetomidine is a well-tolerated and effective agent for both spontaneously breathing and mechanically ventilated patients following congenital cardiac and thoracic surgery.

Pharmacokinetics of dexmedetomidine in postsurgical pediatric intensive care unit patients: Preliminary study*

Dexmedetomidine, administered as a continuous infusion, produces consistent, predictable concentrations in children and infants, and further evaluations of the safety, efficacy, and pharmacodynamics are warranted.

Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit

Abstract Background Dexmedetomidine is an α2-adrenergic agonist that causes sleep-like sedation and mild analgesia without narcosis or respiratory depression, and has relative cardiovascular

Bradycardia During Dexmedetomidine and Therapeutic Hypothermia

  • J. Tobias
  • Medicine
    Journal of intensive care medicine
  • 2008
2 pediatric patients with traumatic brain injury who had good long-term neurologic outcomes, but developed clinically significant bradycardia when therapeutic hypothermia was added to a sedation regimen that included dexmedetomidine and remifentanil are reported.

Dexmedetomidine sedation for pediatric post-Fontan procedure patients

The results of this retrospective review of the role of DEX in the management of the post-Fontan surgical pediatric patient indicate some potential advantages.

Sedation Using Dexmedetomidine in Pediatric Burn Patients

A retrospective chart review of 65 pediatric burn patients admitted in the intensive care unit admitted between 2001 and 2004 who received DEX infusion because of failure to achieve adequate sedation with standard regimen of opioids and benzodiazepines found that DEX would improve sedation compared with standard sedation regimen.